
Lexaria Bioscience (LEXX) Earnings Dates & Reports
Lexaria Bioscience (LEXX) Most Recent Earnings
Report DateJan 10, 2025
Period EndingQ1 2025
Est. EPS-$0.12
Actual EPS-$0.16
EarningsMiss
Lexaria Bioscience (LEXX) Earnings
View the latest Lexaria Bioscience (LEXX) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Lexaria Bioscience (LEXX)
Order type
Buy in
Order amount
Est. shares
0 shares
Lexaria Bioscience (LEXX) Earnings per Share (EPS) History
Signup for full accessBrowse free
Lexaria Bioscience (LEXX) Latest Earnings
The value each LEXX share was expected to gain vs. the value each share gained.
Lexaria Bioscience (LEXX) reported its most recent earnings on Jan 10, 2025 for Q1 2025, posting earnings per share (EPS) of -$0.16. This exceeded analysts' expectations of -$0.12 by 33.33%, marking a Miss.
For comparison, Lexaria Bioscience reported EPS of -$0.13 in the same quarter last year.
The company is expected to announce its next earnings report on 07/15/2025, with analysts projecting an EPS of $0.
Lexaria Bioscience (LEXX) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q3 2025Jul 15, 2025 | – | Next earnings call Jul. 15, 2025 | ||
Q2 2025Apr 14, 2025 | – | -$0.15 | — | |
Q1 2025Jan 10, 2025 | -$0.12 | -$0.16 | +33.33% | |
Q4 2024Nov 26, 2024 | -$0.11 | -$0.15 | +36.36% | |
Q3 2024Jul 12, 2024 | -$0.10 | -$0.13 | +30.00% | |
Lexaria Bioscience (LEXX) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Lexaria Bioscience’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Apr 14, 2025 | — | — | — |
Jan 10, 2025 | — | — | — |
Nov 26, 2024 | — | — | — |
Jul 12, 2024 | — | — | — |
Lexaria Bioscience (LEXX) Earnings FAQs
Lexaria Bioscience (LEXX) last reported earnings on Jan 10, 2025 for Q1 2025, posting an EPS of -$0.16, which Miss the estimate of -$0.12 by 33.33%.
For Q1 2025, Lexaria Bioscience (LEXX) reported an EPS of -$0.16, missing analysts' estimate of -$0.12 by 33.33%.
For Q1 2025, Lexaria Bioscience (LEXX) Miss expectations with an actual EPS of -$0.16 vs. an estimated EPS of -$0.12.
Following the last earnings report on Jan 10, 2025, Lexaria Bioscience (LEXX)'s stock price moved — from — to —.
The next Lexaria Bioscience (LEXX) earnings call is scheduled for Jul. 15, 2025, where executives will discuss financial results and outlook.